Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Metastasis02:30

Metastasis

5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

Cancers·2026
Same author

Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

Cancers·2026
Same author

Insights on Oligometastatic Non-Small-Cell Lung Cancer.

Cancers·2025
Same author

Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies.

Cancers·2025
Same author

Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.

International journal of molecular sciences·2025
Same author

Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches.

International journal of molecular sciences·2025

相关实验视频

Updated: May 26, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1000

寡甲状性NSCLC:当前前的前景和未来的挑战

Sara Torresan1,2, Jacopo Costa1,3, Carol Zanchetta1,3

  • 1Department of Medicine (DME), University of Udine, 33100 Udine, Italy.

Current oncology (Toronto, Ont.)
|February 25, 2025
PubMed
概括

低基质非小细胞肺癌 (NSCLC) 需要精确的定义和多学科的评估,以获得最佳的患者选择. 考虑到疾病的时间和类型,定制的局部区域治疗对于改善这种独特患者群体的生存率至关重要.

关键词:
在NSCLCLC中,我们可以看到.非基因成的NSCLC.这是一种寡头转基因的转基因.这是一种寡头渐进式的.基因上性NSCLC的研究结果

更多相关视频

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.0K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.5K

相关实验视频

Last Updated: May 26, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1000
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.0K
A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

13.5K

科学领域:

  • 在瘤学瘤学.
  • 胸部外科手术 胸部外科手术
  • 医学瘤学 医学瘤学

背景情况:

  • 与广泛传播的第四阶段疾病相比,寡聚性非小细胞肺癌 (NSCLC) 呈现出不同的生物学和预后.
  • 界定寡卵性NSCLC和优化局部治疗策略仍然是重大的临床挑战.
  • 目前的指导方针强调了患者选择的共同标准,包括全面的分期和组织活检.

研究的目的:

  • 审查关于小卵性NSCLC的当前知识,共识和试验数据.
  • 为了澄清在管理小卵性NSCLC的诊断和治疗方面的挑战.
  • 突出个性化治疗策略的需要,并确定未满足的临床需求.

主要方法:

  • 审查国际共识和指导方针.
  • 对回顾性和前性试验数据的分析.
  • 讨论治疗计划的多学科评估.

主要成果:

  • 多学科评估对于确定对激进局部治疗的适应性至关重要.
  • 在量身定制的策略中,区分新发寡头转移性疾病,寡头复发,寡头进展和寡头残留性疾病至关重要.
  • 免疫检查点阻断剂 (ICB) 为非瘤基因成的NSCLC提供了巩固性治疗的新可能性,尽管最佳时间和测序仍在研究中.

结论:

  • 量身定制的本地区域方法对于优化寡头转移性NSCLC的结果至关重要.
  • 新型全身疗法的出现,包括ICB和向药物,需要重新评估治疗模式.
  • 需要进一步的研究,以解决未满足的临床需求,在管理的寡头转移性NSCLC.